Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001056883 | SCV001221348 | uncertain significance | Nemaline myopathy 2 | 2023-08-04 | criteria provided, single submitter | clinical testing | This variant is present in population databases (no rsID available, gnomAD 0.007%). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. ClinVar contains an entry for this variant (Variation ID: 852303). This variant has not been reported in the literature in individuals affected with NEB-related conditions. This sequence change replaces glycine, which is neutral and non-polar, with glutamic acid, which is acidic and polar, at codon 1708 of the NEB protein (p.Gly1708Glu). |
Natera, |
RCV001056883 | SCV002077687 | uncertain significance | Nemaline myopathy 2 | 2021-01-27 | no assertion criteria provided | clinical testing |